In response to updated recommendations from the Centers for Disease Control and Prevention, HNL Lab Medicine will begin subtyping all positive influenza A samples from hospitalized patients to detect H5N1 Highly Pathogenic Avian Influenza. This enhanced surveillance effort is part of a broader initiative to monitor potential bird flu cases […]
Trending News
Konstellate Launches Revolutionary New AI-Powered Platform for Pharma Decision-Makers That Transforms KOL Intelligence
Konstellate, a leading provider of AI technology to power Key Opinion Leaders (KOLs) intelligence for pharma decision-makers, announced today the launch of its new platform. It synthesizes KOL discussions across multiple digital formats to provide pharmaceutical companies with unparalleled insights never before available. The AI-powered platform, with the ability to […]
NeuralCure AI Announces Breakthrough in AI-Powered Healthcare, Completing Decades of Medical Research in Moments
NeuralCure AI, an emerging leader in AI-powered healthcare technology, today unveiled its groundbreaking platform capable of compressing a century of medical research into a single day. By leveraging AI-driven diagnostics and rapid treatment protocol simulations, NeuralCure AI is pioneering perfect-match treatment solutions that seamlessly integrate into research and patient care, […]
JEDMED and Otologic Technologies Announce Partnership to Launch the World’s First AI-Enabled Digital Otoscope
JEDMED Corporation, a global leader in advanced otoscopic solutions, and Otologic Technologies, developer of an artificial intelligence (AI)-driven diagnostic for ear diseases are proud to announce a groundbreaking partnership to deliver the world’s first AI-enabled digital otoscope. Otologic Technologies was founded by Dr. Aaron Moberly of Vanderbilt University Medical Center and Professor Metin Nafi Gurcan of Wake Forest University School […]
Selkirk Pharma Introduces ClinFAST to Expedite Fill/Finish for Clinical Trials
Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the launch of ClinFAST™, a paradigm-shifting service designed to assist clinical stage biotech and pharma companies with a rapid fill/finish process for clinical trial supplies. […]
Midwest Health Purchasers Collaborative Partners with Vida Health to Expand Access to Obesity Specialty Care
As employers face growing challenges in addressing obesity and its related conditions, the Midwest Health Purchasers Collaborative (MHPC), a non-profit employer purchasing organization and arm of the Midwest Business Group on Health, has partnered with Vida Health, a virtual obesity and metabolic center of excellence, to provide employers with cost-effective […]
Spring Health Study Published in JAMA Network Open Demonstrates 1.9x ROI of Employer-Sponsored Behavioral Health Benefits
Spring Health, the leading global mental health solution for employers and health plans, today unveiled data from a peer-reviewed study that validates the return on investment (ROI) of employer-sponsored mental health benefits. The study, published in JAMA Network Open, sets a new benchmark in the behavioral health space, and reveals […]
Alegeus and Empower Forge Partnership to Bring Together Health and Wealth
Alegeus, the market leader in healthcare benefit and payment solutions, today announced it has entered into a major strategic partnership with Empower, a leading provider of retirement and wealth management services. The new partnership coincides with the launch of Empower’s Consumer Directed Health Solutions business and positions the company to […]
Alys Pharmaceuticals receives IND clearance for Phase 2a trial of first genetic medicine program in dermatology
Alys Pharmaceuticals, Inc. (“Alys”), an immune-dermatology focused company, today announces that the U.S. Food and Drug Administration (FDA) and Health Canada have cleared the Investigational New Drug (IND) / Clinical Trial Application (CTA) for the study of ALY-101 in patients suffering from Alopecia Areata (AA). The Phase 2a trial will […]
MYndspan and BIOS Health Partner to Make Consumer-Scale Precision Neuroscience a Reality
MYndspan, a pioneer in consumer brain health technology, and BIOS Health, a leader in real-time neural data analysis and dosing, today announced a partnership to scale the reach and impact of precision neuroscience. By combining MYndspan’s Magnetoencephalography (MEG) powered brain scans with BIOS Health’s proprietary neural data and AI platform, […]
